EPCIP

gene
On this page

Also known as B37PRED81CU062

Summary

EPCIP (exosomal polycystin 1 interacting protein, HGNC:1305) is a protein-coding gene on chromosome 21q22.11, encoding Exosomal polycystin-1-interacting protein (Q9NYP8). Likely to be involved with PKD1 in the detection, sequestration and exocytosis of senescent mitochondria.

Enables identical protein binding activity. Involved in mitocytosis. Located in extracellular exosome and migrasome.

Source: NCBI Gene 56245 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 13 total — 1 pathogenic
  • MANE Select transcript: NM_001162495

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:1305
Approved symbolEPCIP
Nameexosomal polycystin 1 interacting protein
Location21q22.11
Locus typegene with protein product
StatusApproved
AliasesB37, PRED81, CU062
Ensembl geneENSG00000205929
Ensembl biotypeprotein_coding
Entrez56245

Gene structure

Transcript identifiers

Ensembl transcripts: 6 — 6 protein_coding

ENST00000382373, ENST00000479548, ENST00000487113, ENST00000490358, ENST00000861348, ENST00000946954

RefSeq mRNA: 3 — MANE Select: NM_001162495 NM_001162495, NM_001162496, NM_019596

CCDS: CCDS42919

Canonical transcript exons

ENST00000479548 — 4 exons

ExonStartEnd
ENSE000014918713279067332794485
ENSE000018178223280764232807716
ENSE000019157443281359232813703
ENSE000036343403281057432810654

Expression profiles

Bgee: expression breadth ubiquitous, 110 present calls, max score 73.08.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.5775 / max 135.3765, expressed in 120 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
1902150.263372
1902160.262371
1902140.051928

Top tissues by expression

119 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
ovaryUBERON:000099273.08gold quality
left ovaryUBERON:000211972.97gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047371.68gold quality
right ovaryUBERON:000211870.02gold quality
adult mammalian kidneyUBERON:000008269.91gold quality
adenohypophysisUBERON:000219669.84gold quality
pituitary glandUBERON:000000769.76gold quality
corpus callosumUBERON:000233668.58gold quality
metanephros cortexUBERON:001053368.27gold quality
kidneyUBERON:000211367.80gold quality
body of pancreasUBERON:000115064.38gold quality
pancreasUBERON:000126463.89gold quality
hypothalamusUBERON:000189862.23gold quality
islet of LangerhansUBERON:000000662.06gold quality
left uterine tubeUBERON:000130361.68gold quality
cortex of kidneyUBERON:000122561.19gold quality
substantia nigraUBERON:000203857.98gold quality
bone marrow cellCL:000209256.34gold quality
fallopian tubeUBERON:000388956.15gold quality
calcaneal tendonUBERON:000370155.59gold quality
tonsilUBERON:000237255.48gold quality
omental fat padUBERON:001041455.47gold quality
adrenal tissueUBERON:001830355.38gold quality
gall bladderUBERON:000211054.91gold quality
ganglionic eminenceUBERON:000402354.81gold quality
C1 segment of cervical spinal cordUBERON:000646954.45gold quality
colonic epitheliumUBERON:000039753.81gold quality
bone marrowUBERON:000237153.78silver quality
vermiform appendixUBERON:000115453.42gold quality
Ammon’s hornUBERON:000195453.26gold quality

Single-cell (SCXA)

Detected in 4 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-MTAB-8142yes79.70
E-CURD-135no1111.35
E-HCAD-4no78.80
E-ANND-3no1.99

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

95 targeting EPCIP, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-3646100.0073.565283
HSA-MIR-126-5P100.0072.713180
HSA-MIR-6759-5P99.9966.54785
HSA-MIR-366299.9973.825684
HSA-MIR-477599.9875.006394
HSA-MIR-4482-3P99.9872.503147
HSA-MIR-569699.9872.364487
HSA-MIR-60799.9773.625593
HSA-MIR-302C-5P99.9772.563642
HSA-MIR-568899.9673.234504
HSA-MIR-495-3P99.9672.814197
HSA-MIR-1250-3P99.9670.044038
HSA-MIR-6778-3P99.9667.292693
HSA-MIR-590-3P99.9674.346478
HSA-MIR-9983-3P99.9471.483631
HSA-MIR-10527-5P99.9172.283754
HSA-MIR-627-3P99.9071.423316
HSA-MIR-808799.9069.551351
HSA-MIR-153-5P99.8973.866317
HSA-MIR-612499.8769.783551
HSA-MIR-30A-3P99.8769.742928
HSA-MIR-30D-3P99.8769.922917
HSA-MIR-30E-3P99.8769.682942
HSA-MIR-5010-3P99.8370.602357
HSA-MIR-548AZ-5P99.8369.943230
HSA-MIR-548T-5P99.8369.913220
HSA-MIR-684499.8270.692423
HSA-MIR-94499.8270.853042
HSA-MIR-4694-3P99.7969.532640

Literature-anchored findings (GeneRIF, showing 2)

  • The C21orf120 promoter is activated by serum depletion according to promoter reporter assays in HEK 293 cells. (PMID:20494980)
  • Polycystin-1 Interacting Protein-1 (CU062) Interacts with the Ectodomain of Polycystin-1 (PC1). (PMID:37681898)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusEpcipENSMUSG00000039851
rattus_norvegicusEpcipENSRNOG00000028670

Protein

Protein identifiers

Exosomal polycystin-1-interacting proteinQ9NYP8 (reviewed: Q9NYP8)

Alternative names: B37, Polycystin-1-interacting protein 1

All UniProt accessions (2): H7BYF8, Q9NYP8

UniProt curated annotations — full annotation on UniProt →

Function. Likely to be involved with PKD1 in the detection, sequestration and exocytosis of senescent mitochondria.

Subunit / interactions. Homooligomer. Interacts with PKD1 (via the PKD repeats in the N-terminal extracellular region); the interaction is not dependent on N-glycosylation of either protein.

Subcellular location. Vesicle. Secreted. Extracellular exosome.

Tissue specificity. Detected in the kidney and in the endothelium of large blood vessels (at protein level).

Post-translational modifications. N-glycosylated.

Similarity. Belongs to the EPCIP family.

RefSeq proteins (3): NP_001155967, NP_001155968, NP_062542 (=MANE)

Domains & families (InterPro)

IDNameType
IPR029250ECPIPFamily

Pfam: PF15137

UniProt features (7 total): glycosylation site 5, signal peptide 1, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9NYP8-F176.980.35

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Glycosylation sites (5): 29, 42, 95, 188, 210

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 93 (showing top): MODULE_255, MODULE_317, CAGCTG_AP4_Q5, BLALOCK_ALZHEIMERS_DISEASE_UP, MYOD_Q6, BROWN_MYELOID_CELL_DEVELOPMENT_DN, FREAC7_01, GOBP_MITOCHONDRION_LOCALIZATION, chr21q22, GOBP_ESTABLISHMENT_OF_MITOCHONDRION_LOCALIZATION, MODULE_95, GOBP_ORGANELLE_LOCALIZATION, GOBP_MITOCHONDRION_DISTRIBUTION, TGGAAA_NFAT_Q4_01, LEIN_CHOROID_PLEXUS_MARKERS

GO Biological Process (1): mitocytosis (GO:0160040)

GO Molecular Function (2): identical protein binding (GO:0042802), protein binding (GO:0005515)

GO Cellular Component (4): extracellular exosome (GO:0070062), migrasome (GO:0140494), extracellular region (GO:0005576), vesicle (GO:0031982)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
mitochondrion distribution1
establishment of mitochondrion localization1
migracytosis1
protein binding1
binding1
extracellular vesicle1
intracellular membrane-bounded organelle1
cellular anatomical structure1
membrane-bounded organelle1

Protein interactions and networks

STRING

306 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
EPCIPC3orf22Q8N5N4576
EPCIPRNASE12Q5GAN4540
EPCIPSMIM17P0DL12507
EPCIPC12orf56Q8IXR9507
EPCIPSH2D7A6NKC9480
EPCIPCC2D2BQ6DHV5479
EPCIPC1orf167Q5SNV9479
EPCIPC22orf42Q6IC83478
EPCIPANKRD62A6NC57477
EPCIPCLPSL1A2RUU4474
EPCIPFAM131AQ6UXB0473
EPCIPFAM149B1Q96BN6471
EPCIPSPDYE4A6NLX3471
EPCIPRD3LP0DJH9448
EPCIPSMIM21Q3B7S5446

IntAct

9 interactions, top by confidence:

ABTypeScore
EPCIPPKD1psi-mi:“MI:0915”(physical association)0.460
PKD1EPCIPpsi-mi:“MI:0915”(physical association)0.460
PKD1EPCIPpsi-mi:“MI:0403”(colocalization)0.460
EPCIPEPCIPpsi-mi:“MI:0915”(physical association)0.400

ESM2 similar proteins: A9JM73, F5HI32, P04494, P09258, P0C9K4, P0CAE3, P0CAE4, P0CAE5, P0CAE6, P11321, P15137, P16192, P16196, P16200, P16202, P16204, P16206, P16208, P16808, P21526, P21602, P22229, P22282, P22283, P26703, P27908, P27945, P33865, P35767, P35768, P60505, P60506, P67908, P67909, Q00320, Q04547, Q05100, Q2Y2M0, Q65959, Q66653

Diamond homologs: Q9D4G1, Q9NYP8

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

13 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance4
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
1526709GRCh37/hg19 21q21.3-22.12(chr21:27185913-35853445)x1Pathogenic

SpliceAI

353 predictions. Top by Δscore:

VariantEffectΔscore
21:32806568:A:Cdonor_gain1.0000
21:32807643:T:TAdonor_gain1.0000
21:32794481:CTCAC:Cacceptor_gain0.9900
21:32794483:CAC:Cacceptor_gain0.9800
21:32802341:TC:Tdonor_gain0.9800
21:32794484:ACCTG:Aacceptor_loss0.9700
21:32794486:C:Tacceptor_loss0.9700
21:32794487:T:Aacceptor_loss0.9700
21:32794364:G:Cacceptor_gain0.9600
21:32794482:TCAC:Tacceptor_gain0.9600
21:32794483:CACC:Cacceptor_gain0.9600
21:32794930:T:TAdonor_gain0.9600
21:32802342:C:CTdonor_gain0.9600
21:32802343:T:TTdonor_gain0.9600
21:32807640:ACCT:Adonor_gain0.9600
21:32807641:CCTC:Cdonor_gain0.9600
21:32807636:TTTTA:Tdonor_loss0.9500
21:32807637:TTTAC:Tdonor_loss0.9500
21:32807638:TTA:Tdonor_loss0.9500
21:32807639:TAC:Tdonor_loss0.9500
21:32807640:A:Cdonor_loss0.9500
21:32807633:G:Adonor_gain0.9400
21:32794364:G:GCacceptor_gain0.9300
21:32806567:AACTT:Adonor_gain0.9200
21:32807644:C:Adonor_gain0.9200
21:32794488:G:Cacceptor_loss0.9100
21:32807642:C:Adonor_loss0.9100
21:32794486:C:CCacceptor_gain0.8900
21:32806567:A:ACdonor_gain0.8900
21:32806507:G:Tdonor_gain0.8800

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000060357 (21:32810501 T>C), RS1000102137 (21:32795026 T>A), RS1000155007 (21:32809835 G>A), RS1000252370 (21:32809324 C>A), RS1000303408 (21:32813739 G>A), RS1000443061 (21:32801225 T>C), RS1000507791 (21:32796663 C>T), RS1000538864 (21:32796901 C>T), RS1000562613 (21:32794858 A>C), RS1000566956 (21:32790673 T>A), RS1001108610 (21:32813753 C>A,G), RS1001127368 (21:32790917 C>A), RS1001162314 (21:32796311 A>G), RS1001201657 (21:32813199 G>A), RS1001272850 (21:32808781 T>C)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST008832_7Gastroesophageal reflux disease3.000000e-08

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

8 total (human), top 8 by PubMed support.

ChemicalActions (top 5)PubMed papers
propionaldehydedecreases expression1
arseniteaffects binding, increases reaction1
fipronilaffects cotreatment, decreases expression1
Benzo(a)pyreneaffects methylation, decreases methylation1
DEETaffects cotreatment, decreases expression1
Rotenonedecreases expression1
Silicon Dioxideincreases expression1
Tobacco Smoke Pollutiondecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): gastroesophageal reflux disease